Third Wave Technologies has appointed David Arnold to its board of directors. Arnold is a former VP and CTO of Kennametal, where he worked for 24 years.
Fluorotechnics has appointed Günter Thebeling to head its sales and marketing team. Thebeling formerly was strategic marketing director for proteomics products at GE Healthcare and was responsible for managing relationships with pharmaceutical partners and with scientific organizations such as the Human Proteome Organization.
Fran Tuttle has been appointed to join Xceed Molecular’s board of trustees. Tuttle is president and CEO of HX Diagnostics, and formerly was CEO of Protedyne, and senior VP of near patient testing at Bayer Diagnostics. Before that she worked at Chiron Diagnostics.